Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. - Wikidata - wikimedia - TriplyDB

Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial.

Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial.

http://www.wikidata.org/entity/Q34510060

about

Rifaximin for maintenance therapy in antibiotic-dependent pouchitis Dietary and nutritional considerations for inflammatory bowel disease Treatment and prevention of pouchitis after ileal pouch-anal anastomosis for chronic ulcerative colitis Treatment and prevention of pouchitis after ileal pouch-anal anastomosis for chronic ulcerative colitis Probiotics for treating eczema Probiotics for induction of remission in Crohn's disease Probiotics for maintenance of remission in ulcerative colitis Probiotics for non-alcoholic fatty liver disease and/or steatohepatitis Probiotics and medical nutrition therapy Current level of consensus on probiotic science--report of an expert meeting--London, 23 November 2009 From structure to function: the ecology of host-associated microbial communities Potential uses of probiotics in clinical practice Functional modulation of human intestinal epithelial cell responses by Bifidobacterium infantis and Lactobacillus salivarius Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine Dysbiosis in inflammatory bowel disease Probiotic prophylaxis in patients with predicted severe acute pancreatitis (PROPATRIA): design and rationale of a double-blind, placebo-controlled randomised multicenter trial [ISRCTN38327949]Assessment of a new synbiotic preparation in healthy volunteers: survival, persistence of probiotic strains and its effect on the indigenous flora Lactobacillus GG in inducing and maintaining remission of Crohn's disease A monoclonal antibody against kininogen reduces inflammation in the HLA-B27 transgenic rat The intestinal microbiome, barrier function, and immune system in inflammatory bowel disease: a tripartite pathophysiological circuit with implications for new therapeutic directions Diet therapy for inflammatory bowel diseases: The established and the new Microbiota Manipulation With Prebiotics and Probiotics in Patients Undergoing Stem Cell Transplantation The Intestinal Microbiota in Inflammatory Bowel Disease Probiotic-based strategies for therapeutic and prophylactic use against multiple gastrointestinal diseases Development of microencapsulation delivery system for long-term preservation of probiotics as biotherapeutics agent Use of Biologics in Pouchitis: A Systematic Review The role of antibiotics and probiotics in pouchitis Probiotics in inflammatory bowel diseases and associated conditions Mechanisms and therapeutic effectiveness of lactobacilli Intestinal permeability--a new target for disease prevention and therapy Microbiota biodiversity in inflammatory bowel disease Modulation of microbiota as treatment for intestinal inflammatory disorders: An uptodate Probiotic treatment of collagenous colitis: a randomized, double-blind, placebo-controlled trial with Lactobacillus acidophilus and Bifidobacterium animalis subsp. Lactis Systematic review of randomized controlled trials of probiotics, prebiotics, and synbiotics in inflammatory bowel disease The human microbiome and probiotics: implications for pediatrics Fucosyltransferase 2 (FUT2) non-secretor status is associated with Crohn's disease Probiotic supplementation in children with cystic fibrosis-a systematic review.SAMP1/YitFc mouse strain: a spontaneous model of Crohn's disease-like ileitis.Enteric pathogens through life stages.Probiotics promote gut health through stimulation of epithelial innate immunity.

P2860

Q21261868-6DD640D6-EBA3-4D92-BE35-180BFF27795F Q22251396-760F6E59-09F3-4E46-9851-4044F020E192 Q24187707-B46C49CE-DFB7-4094-ADD5-44753054E0C9 Q24234806-0526D60C-8A0C-45A2-B2E9-9ED85C34FA28 Q24241429-E2407D14-EADC-4532-8FDD-3CFAFB4E80FA Q24242115-4C9C7A14-BCFD-47B0-A6AE-B62AE9E4519E Q24242289-6D6F83AB-6A95-4A56-A2B0-1B6C97A95B1C Q24243033-6EEC68B6-294B-4FFB-8DD3-5925F17280E1 Q24548441-0590DE96-1371-49CD-A6A5-0E7BF24FCCA6 Q24601092-2A8387D0-AC5A-4454-BA68-D1DD69380F07 Q24612050-B8BE4363-156C-467B-BE63-025FBE9FFEE1 Q24681377-D1568EC0-F120-463F-921B-AA12CE771868 Q24682955-550FB67A-6D43-4CEB-958A-F7C2D19AAECF Q24685766-C7A725A2-0E45-4024-8E8E-9208EE5E5DA8 Q24685931-372EB697-E1A3-4BD1-A40F-F540D1A0753B Q24791550-5A077C85-E1F5-4439-B4FD-6EC8A758D95D Q24791618-EFC5B213-389F-4ACB-B685-77D7F95977F9 Q24806098-69BA0135-1043-4969-908E-8D937E43CC4C Q24817024-F892C2BD-9442-47D1-89ED-3D340ADF2DA0 Q26745700-9B987976-9FC0-44BB-AB69-0601541AF2B6 Q26768564-EDC7AE5F-512C-42CD-89D1-8ABCA02CB31B Q26771287-D2CDA77D-F471-4F4F-A562-C3E4CCB7391A Q26795705-5F886BA1-0556-48CA-8746-7DFF53598AAA Q26800020-7F1CBE0E-93E8-4493-AF53-115A128EF9D0 Q26991504-06EC5542-FC8E-4B90-ADB7-0CE5E84C8E64 Q26995117-5F321274-5D05-4B2A-9946-D7F61C10DF49 Q27000314-20E3BD9C-C447-4B45-8EB3-F92D5EC78F4A Q27002496-4681D4FB-826E-4572-AE74-0C2D95033676 Q27012999-D9744B55-6DF7-4742-8644-72210D1FAAAA Q27015884-758E0A3A-CBB2-4621-91EB-9DD43535AB62 Q27027772-E512EDF0-2C1C-4247-88E7-0A4A6E54B37B Q28072437-DC267594-B0CB-441A-BBCD-82D7EF5E7C70 Q28238046-E2E45A93-248F-4440-9BA9-A6F5AD7FF086 Q28254207-7700CE6B-AAB4-41CA-917C-07541401614B Q28750959-92E1BAB7-985A-4F43-B035-A95E9BDC6D12 Q29417151-DC53D318-FDB4-49DA-9FE1-815A8B717BD5 Q30248234-66886A30-1A86-44AB-984E-70BB9DBB647B Q30423660-D7E79CD9-273D-4173-9F3A-59A2AB30D3F3 Q30425379-7ED616BA-B25E-4875-A323-B0F7BF56645B Q30437282-8C322B1E-5523-4288-8BD5-E316D5612D29

P2860

Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial.

http://www.wikidata.org/entity/Q34510060

description

2000 nî lūn-bûn

@nan

2000 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2000 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2000年の論文

@ja

2000年論文

@yue

2000年論文

@zh-hant

2000年論文

@zh-hk

2000年論文

@zh-mo

2000年論文

@zh-tw

2000年论文

@wuu

name

Oral bacteriotherapy as mainte ...... ind, placebo-controlled trial.

@ast

Oral bacteriotherapy as mainte ...... ind, placebo-controlled trial.

@en

Oral bacteriotherapy as mainte ...... ind, placebo-controlled trial.

@nl

type

label

Oral bacteriotherapy as mainte ...... ind, placebo-controlled trial.

@ast

Oral bacteriotherapy as mainte ...... ind, placebo-controlled trial.

@en

Oral bacteriotherapy as mainte ...... ind, placebo-controlled trial.

@nl

prefLabel

Oral bacteriotherapy as mainte ...... ind, placebo-controlled trial.

@ast

Oral bacteriotherapy as mainte ...... ind, placebo-controlled trial.

@en

Oral bacteriotherapy as mainte ...... ind, placebo-controlled trial.

@nl

P1433

Q34510060-F2B55355-ED77-4C93-98CA-CA11E3D4B2A7

P1476

Q34510060-D096C62F-BEEE-43B8-870C-A6D91C566122

P2093

Q34510060-1951860A-7125-4FCE-8AEF-973C00BB5750

Q34510060-2285EE5E-DD16-48D6-9898-A7D1B69CDC21

Q34510060-3F9B752E-04F7-4F85-84DD-266E985F9F6B

Q34510060-7B0FB6FE-96E0-4492-A827-C032FAF117DF

Q34510060-849B6622-E932-437A-BACC-A85380345F98

Q34510060-95A021EE-B3D8-45B1-88F2-069942582999

Q34510060-AA0197AE-2456-4FD5-A7CA-AA09434E9E5D

Q34510060-BFE45250-2784-479C-87C0-0A7DC8ABE9DB

Q34510060-CB50F8AB-703C-4BE9-B710-AA2017DD6DEB

P304

Q34510060-EA172E25-2E07-4183-9000-65135B9BCD33

P31

Q34510060-1BAAD984-FBF6-41F5-B068-C8279AF37DB8

P356

Q34510060-B762A5D8-6BB0-44CE-BB80-68BDA39C35DB

P407

Q34510060-5088A2ED-BEFF-4976-BBE9-7CE3211F3D99

P433

Q34510060-6DD0151A-74CD-4F97-9924-884D6F95B96C

P478

Q34510060-3CB25132-4041-4073-9963-F6397FD3C1E4

P577

Q34510060-922DA265-FA39-4A97-8EE9-F30560C73DA0

P5875

Q34510060-6FDDC6E0-1244-4560-B339-37F2CDEFFC16

P698

Q34510060-6991C46A-7FA5-4B47-9E2C-84EC87B4FC30

P921

Q34510060-01FEC54F-A27E-4FCD-B05E-7B8BFC069FF1

Q34510060-A377F5A4-259D-42A1-A7B8-5963F5D2DDC4

P356

P1433

Gastroenterology

P1476

Oral bacteriotherapy as mainte ...... ind, placebo-controlled trial.

@en

P2093

Bazzocchi G

http://www.w3.org/2001/XMLSchema#string

Brigidi P

http://www.w3.org/2001/XMLSchema#string

Campieri M

http://www.w3.org/2001/XMLSchema#string

Gionchetti P

http://www.w3.org/2001/XMLSchema#string

Matteuzzi D

http://www.w3.org/2001/XMLSchema#string

Miglioli M

http://www.w3.org/2001/XMLSchema#string

Poggioli G

http://www.w3.org/2001/XMLSchema#string

Rizzello F

http://www.w3.org/2001/XMLSchema#string

Venturi A

http://www.w3.org/2001/XMLSchema#string

P304

305-309

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1053/GAST.2000.9370

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

119

http://www.w3.org/2001/XMLSchema#string

P577

2000-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

12390983

http://www.w3.org/2001/XMLSchema#string

P698

10930365

http://www.w3.org/2001/XMLSchema#string

P921